Epinephrine intranasal (Nasus Pharma)

N/A

Report date: 2025/07/03 20:00:09

Base Information

Drug NameEpinephrine intranasal (Nasus Pharma)
Drug Alias NameFMXIN-002NS-002
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsFood HypersensitivityAnaphylaxisHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaIsrael
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNasus Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNasus Pharma
Inactive CompaniesN/A
Active IndicationsFood HypersensitivityAnaphylaxisHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A